Business Wire

Open letter to Europe by André Rogaczewski CEO and co-founder of Netcompany: Europe must stand tall

23.4.2025 06:30:00 CEST | Business Wire | Press release

Share

On the night of 22 April, the Statue of Liberty at Pont de Grenelle in Paris was illuminated with the message: “Stand Tall Europe”. Once a gift symbolising the transatlantic alliance and shared ideals of the West, the statue now stands as a reminder of a fellowship through centuries that is put under heavy pressure.

The following is an open letter by André Rogaczewski CEO and co-founder of Netcompany:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422921783/en/

Statue of Liberty at Pont de Grenelle last night in Paris – Iluminated with the message ”Stand Tall Europe”.

Europeans,

This is your digital awakening.

We all know that leading technologically is paramount for competitiveness and the creation of growth, prosperity, and welfare.

Europe’s digital backbone is to a large extent built on systems we don’t necessarily control. From data centers to cloud systems – in the applications and algorithms that shape our decisions.

While we rely on digital services in all our core societal areas— communication, financial services, welfare benefits, pensions, healthcare, even elections—the digital applications and infrastructures behind are too often dependent on non-European systems.

What we need is a response. To protect our individual rights, and shape a digital European ecosystem rooted in our own democratic values – not those imposed by people who no longer necessarily share our beliefs.

That’s why Netcompany launched a campaign on the night of 22 April by illuminating the Statue of Liberty in Paris with the message: “Stand Tall Europe”.

We chose the Statue of Liberty because it stands as a symbol of freedom, justice, the end of oppression, and opportunity for all. A gift from Europe to the US symbolising the values we created together and used to share. It seems now that Europe herself alone is facing the challenge of protecting those same ideals in a digital world.

Where the Statue of Liberty lifts a torch, Europe’s task today is to light the digital path forward—by asserting digital sovereignty, defending rights online, and building our own trusted secure systems and applications that our societies can rely on and prosper with.

We must embrace the digital revolution, establish more European datacenters, set up trusted age-verification systems to protect our children, and ensure our voters are not filled with digital propaganda.

We must quickly build trustworthy, robust, fair, and transparent applications and systems showing everyone else that responsible digital transformation is the way to create world-leading innovation, growth and progress.

That means offensively using AI designed with European values and transparency to create efficient European private and public administration. It means developing intelligent digital twins for our physical infrastructure across all industries to uniquely optimise European businesses. In fact, we must build world leading digital applications for Europe to become a leading region of the world.

We are calling for more European solutions—built by European companies, accountable to European citizens.

Europe’s future prosperity and growth depends on it and hence it also depends on our ability to attract, develop, and unite diverse world-class talent from everywhere.

We must make this continent the most attractive destination for the world’s sharpest minds.

This is also a call for all of you who want to contribute to the European digital awakening, wherever you are. We need you.

There’s no quick fix. But we are ready. We believe in a digital future where Europe owns more of its systems, protects its citizens, and leads with integrity.

Let’s take back the future.

Yours sincerely,

André Rogaczewski

CEO and co-founder of Netcompany

About André Rogaczewski

​André Rogaczewski founded Netcompany in 2000 and has overseen its evolution into one of Europe’s fastest growing and most successful IT services companies, with a global headcount of +8,250 talented employees across +10 European countries.

With his technical background, a master's degree in computer science from Aalborg University and a true vision for society’s digital future, he has led the company through tremendous growth and built a unique delivery model unmatched elsewhere in the IT industry. André was born in Poland and grew up in Aalborg, Denmark.

About Netcompany

Founded in 2000 in Copenhagen, Denmark, Netcompany provides essential IT solutions for both societal and business needs, aiding our private and public clients in their digital evolution towards a more efficient and sustainable future.

Our team of skilled professionals drives sustainable innovation, consistently advancing and expanding our impact - one solution at a time.

By building flexible, scalable and secure digital solutions, we help Europe lead the way towards responsible digitalisation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250422921783/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye